10
Participants
Start Date
June 30, 2013
Primary Completion Date
February 28, 2015
Study Completion Date
May 31, 2015
Bevacizumab
Johns Hopkins Hospital, Baltimore
Collaborators (1)
Genentech, Inc.
INDUSTRY
Guthy Jackson Charitable Foundation
OTHER
Johns Hopkins University
OTHER